Purchases and Sales Made in Q4 2024 in Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID) during Q4 2024. The information is specifically focused on institutions that hold shares of Ovid Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-11K- 10.61% |
$10.3K - $15K
|
93K
$39K
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-16.2K- 18.75% |
$15K - $22K
|
70.1K
$29.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-24.1K- 62.82% |
$22.4K - $32.8K
|
14.3K
$6K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-45.5K- 3.11% |
$42.3K - $61.9K
|
1.42M
$596K
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-80.4K- 25.98% |
$74.8K - $109K
|
229K
$96.2K
|
|
|
Feb 12, 2025
Q4 2024
|
Tls Advisors LLC
Miami, FL |
SELL
|
- |
-90.6K- 11.74% |
$84.2K - $123K
|
681K
$286K
|
|
|
Feb 07, 2025
Q4 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-137K- 52.56% |
$127K - $186K
|
124K
$51.9K
|
|
|
Feb 14, 2025
Q4 2024
|
Madison Avenue Partners, LP
New York, NY |
SELL
|
- |
-394K- 9.57% |
$367K - $536K
|
3.72M
$1.56M
|